India's generic drug maker Glenmark draws up a US-based branded drugs unit
Israel’s Teva — the world’s largest generic drugmaker — isn’t the only one looking to capitalize on branded drugs. Indian generic drug manufacturer Glenmark is making innovative drugs a priority too, by spinning off its roster of new chemical and biological entities into a US-based unit.
The bulk of Glenmark’s business is generics, but it has started adding some specialty treatments to the mix – in its last reported quarter, Glenmark made a foray into the dermatology drugs business in the United States by acquiring the rights to seven branded products from Exeltis USA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.